REQUEST A DEMO
Total
USD $0.00
Search more companies

Alebund Pharmaceuticals (Jiangsu) Ltd. (礼邦医药(江苏)股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Alebund Pharmaceuticals (Jiangsu) Ltd. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Alebund Pharmaceuticals (Jiangsu) Ltd. (礼邦医药(江苏)股份有限公司) is a company based in China, with its head office in Yangzhou. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on May 20, 2021.

Legal Address
Building 7, No.7 Jinzhuang Road, High-tech Zone, Hanjiang District, Yangzhou City
Yangzhou; Jiangsu; Postal Code: 225100

Contact Details: Purchase the Alebund Pharmaceuticals (Jiangsu) Ltd. (礼邦医药(江苏)股份有限公司) report to view the information.

Basic Information
Registered Capital:
Purchase the Alebund Pharmaceuticals (Jiangsu) Ltd. (礼邦医药(江苏)股份有限公司) report to view the information.
Financial Auditors:
Purchase the Alebund Pharmaceuticals (Jiangsu) Ltd. (礼邦医药(江苏)股份有限公司) report to view the information.
Incorporation Date:
May 20, 2021
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
9.58%
Purchase this report to view the information.
8.52%
Purchase this report to view the information.
8.19%
Purchase this report to view the information.
7.28%
Purchase this report to view the information.
7%
Subsidiaries
Li Bang Pharmaceutical (Shanghai) Co., Ltd
100%
Shanghai Libang Pharmaceutical Science and Technology Co., Ltd
100%
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
No results were found for this company.

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?